Mometasone topical solution 0.1% (equiv to Elocon topicallotion)
Mometasone topical solution 0.1% (equiv to Elocon topicallotion)
AIGIS INDUSTRIES
Octreotide injection 0.2 mg/mL (base) and 1 mg/mL (base) (equiv to Sandostatin injection)
BEDFORD
Fexofenadine/pseudoephedrine extended-release tablets 60/120 mg (equiv to Allegra D extended-release tablets)
BARR
Anagrelide capsules 0.5 mg (base) and 1 mg (base) (equiv to Agrylin capsules)
IMPAX, IVAX, ROXANE, WATSON, BARR, EON, MYLAN
Tramadol/acetaminophen tablets 37.5/325 mg (equiv to Ultracet tablets)
KALI LABORATORIES
Clozapine tablets 50 mg (equiv to Clozaril tablets)
IVAX
Doxycycline tablets 20 mg (equiv to Periostat tablets)
MUTUAL PHARMACEUTICAL COMPANY, IVAX, WEST-WARD
Fenofibrate tablets 54 and 160 mg (equiv to Tricor tablets)
TEVA
Ceftriaxone for injection 10 g/vial (pharmacy bulk package) (equiv to Rocephin for injection)
SANDOZ
Foscarnet injection 24 mg/mL, 250 and 500 mL bottles (equiv to Foscavir injection)
PHARMAFORCE
David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2
July 1st 2020In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.
Listen
Are PBMs Putting GLP-1 Drugs on Their Formularies?
October 11th 2024PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is uneven. What is needed is more data about whether these drugs can lower overall healthcare costs.
Read More